SYS ONLINE
Supplements/Compound

XOS (Xylooligosaccharides)

Low-dose prebiotic from xylan.

Buy

Overview

Low-dose prebiotic from xylan.

Natural sources
  • Endogenously produced or biosynthesized molecule
  • Standardized pharmaceutical- or food-grade supplement
  • Combined with cofactors that improve absorption or activity
Common forms
  • Capsule or softgel
  • Powder
  • Sublingual or buccal
  • Liposomal liquid

Mechanism of action

Selectively bifidogenic at low doses.

Pathways
  • · Selectively bifidogenic at low doses

Effects on the body

Supports
bowel function

Organ system effects

Digestive / Gut

XOS (Xylooligosaccharides) influences gut motility, mucosal integrity, or microbial balance in the GI tract.

Evidence-based benefits

Improves bowel function

Moderate evidence

Potential side effects

Common
  • · Mild bloating
Rare
    Serious

      Drug interactions

      Prescription medications (general)
      Always disclose XOS (Xylooligosaccharides) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
      minor

      Supplement interactions

      Pairs well with
      • Multi-strain probiotic
        Supports microbiome diversity and barrier integrity.
      • L-glutamine
        Substrate for enterocyte energy and tight-junction maintenance.
      Avoid combining with

      No specific avoidances listed.

      Dosing & bioavailability

      Typical dose
      1–4 g
      Best form
      Most evidence is based on the capsule or softgel form.
      Timing
      Consistent daily timing recommended; split larger doses if GI tolerance is a concern.
      With food?
      With a meal containing fat for fat-soluble compounds; otherwise either.

      Where to buy

      Affiliate links — we may earn a commission at no extra cost to you. Amazon code supplementsch-20 is auto-applied at checkout. We don't endorse specific brands; verify third-party testing (USP, NSF, Informed Sport) before purchase.

      Scientific evidence8Show studies
      RCTBr J Nutr · 2010

      XOS prebiotic

      Mäkeläinen H, et al.

      13 adults

      Key findings

      Increased bifidobacteria at 2 g.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: XOS (Xylooligosaccharides) — Improves bowel function

      Live PubMed search

      Live results for "XOS (Xylooligosaccharides) Improves bowel function" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching XOS (Xylooligosaccharides) and "Improves bowel function". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: XOS (Xylooligosaccharides) — randomized controlled trial

      Live PubMed search

      Live results for "XOS (Xylooligosaccharides) randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching XOS (Xylooligosaccharides) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: XOS (Xylooligosaccharides) — meta-analysis

      Live PubMed search

      Live results for "XOS (Xylooligosaccharides) meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching XOS (Xylooligosaccharides) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: XOS (Xylooligosaccharides) — pharmacokinetics

      Live PubMed search

      Live results for "XOS (Xylooligosaccharides) pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching XOS (Xylooligosaccharides) and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: XOS (Xylooligosaccharides) — safety adverse events

      Live PubMed search

      Live results for "XOS (Xylooligosaccharides) safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching XOS (Xylooligosaccharides) and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: XOS (Xylooligosaccharides) — dose response

      Live PubMed search

      Live results for "XOS (Xylooligosaccharides) dose response" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching XOS (Xylooligosaccharides) and "dose response". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewGoogle Scholar · 1970

      Google Scholar: XOS (Xylooligosaccharides) — clinical evidence

      Live Scholar search

      Cross-database citation index for XOS (Xylooligosaccharides) as it relates to "clinical evidence".

      Key findings

      Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

      Open study
      Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.

      Community discussion

      (0 threads)

      Share your experience or read what others have tried. Anecdotes are not medical advice.

      Sign in or create a free account to post or reply.
      Loading discussion…